These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30862498)

  • 21. The subcellular dynamics of GPCR signaling.
    Calebiro D; Koszegi Z
    Mol Cell Endocrinol; 2019 Mar; 483():24-30. PubMed ID: 30610913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How Ligands Illuminate GPCR Molecular Pharmacology.
    Wacker D; Stevens RC; Roth BL
    Cell; 2017 Jul; 170(3):414-427. PubMed ID: 28753422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening.
    Eglen RM; Bosse R; Reisine T
    Assay Drug Dev Technol; 2007 Jun; 5(3):425-51. PubMed ID: 17638542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
    Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y
    Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible G Protein βγ9 Distribution-Based Assay Reveals Molecular Underpinnings in Subcellular, Single-Cell, and Multicellular GPCR and G Protein Activity.
    Senarath K; Ratnayake K; Siripurapu P; Payton JL; Karunarathne A
    Anal Chem; 2016 Dec; 88(23):11450-11459. PubMed ID: 27778511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.
    Lee SM; Booe JM; Pioszak AA
    Eur J Pharmacol; 2015 Sep; 763(Pt B):196-205. PubMed ID: 25981303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. G protein-coupled receptor transmembrane binding pockets and their applications in GPCR research and drug discovery: a survey.
    Kratochwil NA; Gatti-McArthur S; Hoener MC; Lindemann L; Christ AD; Green LG; Guba W; Martin RE; Malherbe P; Porter RH; Slack JP; Winnig M; Dehmlow H; Grether U; Hertel C; Narquizian R; Panousis CG; Kolczewski S; Steward L
    Curr Top Med Chem; 2011; 11(15):1902-24. PubMed ID: 21470172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulating G-protein-coupled receptors: from traditional pharmacology to allosterics.
    Gilchrist A
    Trends Pharmacol Sci; 2007 Aug; 28(8):431-7. PubMed ID: 17644194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
    Bermudez M; Wolber G
    Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oligomerization of GPCRs involved in endocrine regulation.
    Kleinau G; Müller A; Biebermann H
    J Mol Endocrinol; 2016 Jul; 57(1):R59-80. PubMed ID: 27151573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deuteration as a General Strategy to Enhance Azobenzene-Based Photopharmacology.
    Roßmann K; Gonzalez-Hernandez AJ; Bhuyan R; Schattenberg C; Sun H; Börjesson K; Levitz J; Broichhagen J
    Angew Chem Int Ed Engl; 2024 Sep; 63(39):e202408300. PubMed ID: 38897926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and Function of Peptide-Binding G Protein-Coupled Receptors.
    Wu F; Song G; de Graaf C; Stevens RC
    J Mol Biol; 2017 Aug; 429(17):2726-2745. PubMed ID: 28705763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Light- and drug-activated G-protein-coupled receptors to control intracellular signalling.
    Masseck OA; Rubelowski JM; Spoida K; Herlitze S
    Exp Physiol; 2011 Jan; 96(1):51-6. PubMed ID: 21041315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orthogonal Optical Control of a G Protein-Coupled Receptor with a SNAP-Tethered Photochromic Ligand.
    Broichhagen J; Damijonaitis A; Levitz J; Sokol KR; Leippe P; Konrad D; Isacoff EY; Trauner D
    ACS Cent Sci; 2015 Oct; 1(7):383-93. PubMed ID: 27162996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane potentials regulating GPCRs: insights from experiments and molecular dynamics simulations.
    Vickery ON; Machtens JP; Zachariae U
    Curr Opin Pharmacol; 2016 Oct; 30():44-50. PubMed ID: 27474871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Pharmacochaperone-Based High-Throughput Screening Assay for the Discovery of Chemical Probes of Orphan Receptors.
    Morfa CJ; Bassoni D; Szabo A; McAnally D; Sharir H; Hood BL; Vasile S; Wehrman T; Lamerdin J; Smith LH
    Assay Drug Dev Technol; 2018 Oct; 16(7):384-396. PubMed ID: 30251873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in tethered photopharmacology for precise optical control of signaling proteins.
    Broichhagen J; Levitz J
    Curr Opin Pharmacol; 2022 Apr; 63():102196. PubMed ID: 35245800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.
    Filizola M; Weinstein H
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):577-84. PubMed ID: 16159019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An update on the physiological and therapeutic relevance of GPCR oligomers.
    Farran B
    Pharmacol Res; 2017 Mar; 117():303-327. PubMed ID: 28087443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of BRET for studying G protein-coupled receptors.
    Kaczor AA; Makarska-Bialokoz M; Selent J; de la Fuente RA; Martí-Solano M; Castro M
    Mini Rev Med Chem; 2014 May; 14(5):411-25. PubMed ID: 24766382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.